Merck Announces New Data from Phase 3 Trials Evaluating the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) in Adults with Virologically Suppressed HIV-1 Infection

News > Health News

Carbonatix Pre-Player Loader

Audio By Carbonatix

5:45 AM on Wednesday, October 15

The Associated Press
This content is used here with permission. To view the original visit: https://www.businesswire.com/news/home/20251015084865/en/
 

You might also be interested in:

Sponsored Links

Trending Videos

Salem News Channel Today

Trending Videos

On Air & Up Next

  • Bloomberg Radio
    12:00AM - 1:00AM
     
    Bloomberg Radio is the world's only global 24-hour business radio station.   >>
     
  • Best Stocks Now
    1:00AM - 2:00AM
     
    Bill Gunderson provides listeners with financial guidance that is both   >>
     
  • Bloomberg Radio
    2:00AM - 3:00AM
     
    Bloomberg Radio is the world's only global 24-hour business radio station.   >>
     
  • The Ramsey Show
    3:00AM - 6:00AM
     
    Millions listen to The Ramsey Show every day for common-sense talk on money.   >>
     
  • Bloomberg Radio
    6:00AM - 7:00AM
     
    Bloomberg Radio is the world's only global 24-hour business radio station.   >>
     

See the Full Program Guide